Business Development

Full-spectrum partnering support in the Nordics for US biotech

Brief

Boots on the ground crucial to immuno-oncology partnering and negotiations

May 25th 2021

2 min read

Contact

Ulrika Vintmyr

Director

At a glance

  • Complete search, screening and selection of biotech companies and assets
  • Technical platform mapping and light corporate due diligence
  • Shortlisting of partnering candidates including early negotiations

COMPLICATION

An immuno-oncology biotech company, headquartered in New York, had recently signed a global collaboration-license agreement with a big pharma company worth 1 billion USD allowing our client to expand their existing portfolio.

The vibrant oncology biotech market in the Nordics was a specific target for our client, but without local affiliates the initial outreach and sourcing was complicated.

Szpirt & Company was hired to provide on the ground support in the Nordics to source partnering opportunities specifically in the field of immunotherapy.

SOLUTION

We executed a complete search, screening and selection of biotech candidates, mapping and analysing the technical platforms, key assets and lead candidates in terms of a strategic fit.

In total ten biotechs were shortlisted for executive partnering meetings with our client.

Szpirt & Company facilitated the early negotiations with the shortlisted candidates including C-suite presentation rounds. After the first round of partnering meetings we provided support in the second round of negotiations.

Ready to talk?

We work with ambitious clients who want to make an impact. Please provide your email and a short subject line and we’ll get right back to you.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.